News & Updates
Filter by Specialty:
5-ASA maintenance therapy of little help in patients with newly diagnosed CD
Maintenance treatment with 5-aminosalicylates (5-ASA) in patients with newly diagnosed Crohn's disease (CD) does not appear to lead to better outcomes as compared with a watchful waiting approach, according to a study.
5-ASA maintenance therapy of little help in patients with newly diagnosed CD
23 Mar 2023
Response to therapy higher in clinical trial than real-world RCC patients
Among patients with metastatic renal cell carcinoma (RCC) who have received first-line therapies, complete response rates are lower in the real-world population than in the clinical trial population, reports a recent study. Complete response predicts a favourable overall survival.
Response to therapy higher in clinical trial than real-world RCC patients
22 Mar 2023
Through the lens of a Radiologist
Medical Protection represented a consultant neuroradiologist where it was alleged that Dr B negligently interpreted an MRI scan. Peter J Mordecai, claims manager at Medical Protection, explores the issues in this type of claim. Medical Protection acknowledges the contribution to this article from Raja, Darryl & Loh.
Through the lens of a Radiologist
22 Mar 2023
Menopausal hormone therapy use carries increased T2DM risk
The use of menopausal hormone therapy (MHT), including the most prescribed agent tibolone, appears to contribute to an increase in the risk of type 2 diabetes mellitus (T2DM), as shown in a retrospective study.
Menopausal hormone therapy use carries increased T2DM risk
21 Mar 2023
Neurologic disability predicts severe ED in men infected with HTLV-1
Patients with human T-lymphotropic virus 1 (HTLV-1) infection may develop erectile dysfunction (ED), and time to progression to its severe form is significantly associated with the degree of neurologic compromise at baseline, reveals a study.
